Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinjie Zhou

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Therapy. Nucleic Acids|February 22, 2021
circRNA hsa_circ_0018414 inhibits the progression of LUAD by sponging miR-6807-3p and upregulating DKK1Yuanshan Yao, Yinjie Zhou, Qingwang Hua
Pakistan Journal of Pharmaceutical Sciences|September 26, 2019
Comparing efficacy and safety of regorafenib versus pemetrexed in lung cancer: A preliminary clinical trial evaluating effect of inflammatory biomarkers on disease progressionYuanshan Yao, Yinjie Zhou, Qingwang Hua
Biochemical and Biophysical Research Communications|November 25, 2018
CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathwayYuanshan Yao, Qingwang Hua, Yinjie Zhou
Molecular Medicine Reports|January 22, 2019
miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2Yuanshan Yao, Yinjie Zhou, Xiaojun Fu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 28, 2018
[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy]Yuanshan Yao, Yinjie Zhou, Zhenhua Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2019
CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathwayYuanshan Yao, Qingwang Hua, Yinjie Zhou, et al.
Oncology Research|March 11, 2018
Adjuvant Chemotherapy Following Surgical Resection Improves Survival in Patients With Early Stage Small Cell Lung CancerYuanshan Yao, Yinjie Zhou, Zhenhua Yang, et al.
Oncology Letters|March 20, 2018
Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimerYuanshan Yao, Haibo Shen, Yinjie Zhou, et al.
Frontiers in Robotics and AI|June 24, 2025
Toward an active exoskeleton with full energy autonomyYakir Knafo, Yinjie Zhou, Avi Manor, et al.
Medicine|April 28, 2025
Bidirectional Mendelian randomization and potential mechanistic insights into the causal relationship between gut microbiota and malignant mesotheliomaYinjie Zhou, Huangkai Zhu, Long Zhao, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Nucleic Acids|February 22, 2021
circRNA hsa_circ_0018414 inhibits the progression of LUAD by sponging miR-6807-3p and upregulating DKK1Yuanshan Yao, Yinjie Zhou, Qingwang Hua
Pakistan Journal of Pharmaceutical Sciences|September 26, 2019
Comparing efficacy and safety of regorafenib versus pemetrexed in lung cancer: A preliminary clinical trial evaluating effect of inflammatory biomarkers on disease progressionYuanshan Yao, Yinjie Zhou, Qingwang Hua
Biochemical and Biophysical Research Communications|November 25, 2018
CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathwayYuanshan Yao, Qingwang Hua, Yinjie Zhou
Molecular Medicine Reports|January 22, 2019
miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2Yuanshan Yao, Yinjie Zhou, Xiaojun Fu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|June 28, 2018
[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy]Yuanshan Yao, Yinjie Zhou, Zhenhua Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2019
CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathwayYuanshan Yao, Qingwang Hua, Yinjie Zhou, et al.
Oncology Research|March 11, 2018
Adjuvant Chemotherapy Following Surgical Resection Improves Survival in Patients With Early Stage Small Cell Lung CancerYuanshan Yao, Yinjie Zhou, Zhenhua Yang, et al.
Oncology Letters|March 20, 2018
Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimerYuanshan Yao, Haibo Shen, Yinjie Zhou, et al.
Frontiers in Robotics and AI|June 24, 2025
Toward an active exoskeleton with full energy autonomyYakir Knafo, Yinjie Zhou, Avi Manor, et al.
Medicine|April 28, 2025
Bidirectional Mendelian randomization and potential mechanistic insights into the causal relationship between gut microbiota and malignant mesotheliomaYinjie Zhou, Huangkai Zhu, Long Zhao, et al.
Pageof 2